Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin.
Tsuchihashi K, Kusaba H, Yoshihiro T, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Imajima T, Shinohara Y, Ito M, Yamaga S, Tanoue K, Arimizu K, Ohmura H, Hanamura F, Yamaguchi K, Isobe T, Ariyama H, Nakashima Y, Akashi K, Baba E.
Tsuchihashi K, et al. Among authors: endo m.
Sci Rep. 2020 Dec 1;10(1):20896. doi: 10.1038/s41598-020-77898-y.
Sci Rep. 2020.
PMID: 33262403
Free PMC article.